πŸ‡ΊπŸ‡Έ FDA
Patent

US 9701733

Maspin-based treatment of cancer

granted A61KA61K38/00A61P

Quick answer

US patent 9701733 (Maspin-based treatment of cancer) held by Northwestern University expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/00, A61P, A61P19/10, A61P35/00